Heteroatom Chemistry
9
biological evaluation to support the ꢂndings of this study are
included within the supplementary information ꢂle.
derived from pyridine-2-carbaldehyde: Crystal structure of a
binuclear complex ,” Polyhedron, vol. 26, no. 4, pp. 818–828, 2007.
[
10] D. K. Demertzi, J. R. Miller, N. Kourkoumelis, S. K. Had-
jikakou, and M. A. Demertzis, “Palladium(II) and platinum(II)
complexes of pyridine-2-carbaldehyde thiosemicarbazone with
potential biological activity. Synthesis, structure and spectral
properties. Extended network via hydrogen bond linkages of
Conflicts of Interest
Te authors declare that there are no conꢁicts of interest
regarding the publication of this paper.
[
Pd(Pyꢀsc)Cl] ,” Polyhedron, vol. 18, no. 7, pp. 1005–1013, 1999.
11] S. Rajeev, D. Kumar, S. Bhoop, V. Singh, and K. R. Sharma,
Molecular structure, vibrational spectroscopic and HOMO,
Acknowledgments
[
“
Te authors acknowledge Osmania University, JNꢀ Uni-
versity Hyderabad, and School of Chemistry, University of
Hyderabad, for providing research facilities to carry out this
work.
LUMO studies of S-2-picolyl-ꢉ-N-(2-acetylpyrrole) dithio-
carbazate schiꢃ base by quantum chemical investigations,”
Research Journal of Chemical Sciences, vol. 3, pp. 79–84, 2013.
[
12] R. Singh, D. Kumar, Y. C. Goswami, and R. Sharma, “Syn-
thesis, spectral studies and quantum-chemical investigations
on S-benzyl ꢉ-N-(4-NN biscynodiethylaminophenylmethy-
lene)dithiocarbazate ,” Arabian Journal of Chemistry, 2014.
Supplementary Materials
Molecular graphs of the ligand (H4FPꢀ) and spectra of the
ligand and its Ni(II) and Cu(II) complexes are incorporated
as supplementary material mentioned as Figures S1–S7. Agar
plates showing antibacterial activity of H4FPꢀ (L) and its
Ni(II) and Cu(II) complexes with zone of inhibition are
presented in Figure S8. Te ꢁuorescence emission data of
[13] Z. Almi, S. Belaidi, ꢀ. Lanez, and N. ꢀchouar, “Structure activity
relationships, QSAR modeling and drug-like calculations of ꢀP
inhibition of 1,3,4-oxadiazoline-2-thione derivatives ,” Interna-
tional Letters of Chemistry, Physics and Astronomy, vol. 37, pp.
113–124, 2014.
[14] S. P. Mydhili, B. Sireesha, and Ch. Venkata Ramana Reddy,
“Synthesis, DNA binding, cleavage and antibacterial studies of
nickel (ii) and copper (II) complexes of 4-formylpyridine N (4)-
methylthiosemicarbazone ,” Journal of Chemical and Pharma-
ceutical Research, vol. 8, pp. 78–85, 2016.
References
[
1] M. Frezza, S. Hindo, D. Chen et al., “Novel metals and metal
complexes as platforms for cancer therapy ,” Current Pharma-
ceutical Design, vol. 16, no. 16, pp. 1813–1825, 2010.
[
15] S. Chandra, S. Raizada, M. ꢀyagi, and P. K. Sharma, “Spectro-
scopic and biological approach of Ni(II) and Cu(II) complexes
of 2-pyridinecarboxaldehyde thiosemicarbazone ,” Spectrochim-
ica Acta Part A: Molecular and Biomolecular Spectroscopy, vol.
[
2] U. Ndagi, N. Mhlongo, and M. E. Soliman, “Metal complexes in
cancer therapy - an update from drug design perspective ,” Drug
Design, Development and ꢀerapy, vol. 11, pp. 599–616, 2017.
69, no. 3, pp. 816–821, 2008.
[
16] H. Wu, ꢀ. Sun, K. Li et al., “Synthesis, crystal structure, and
DNA-binding studies of a nickel(II) complex with the bis(2-
benzimidazolymethyl)amine ligand ,” Bioinorganic Chemistry
and Applications, vol. 2012, Article ID 609796, 7 pages, 2012.
[
3] M. P. M. Marques, “Platinum and palladium polyamine com-
plexes as anticancer agents: the structural factor ,” ISRN Spec-
troscopy, vol. 2013, Article ID 287353, 29 pages, 2013.
[
4] S. Chandra, M. ꢀyagi, and M. S. Refat, “Spectroscopic, thermal
and antibacterial studies of Mn(II) and Co(II) complexes
derived from thiosemicarbazone ,” Journal of the Serbian Chem-
ical Society, vol. 74, no. 8-9, pp. 907–915, 2009.
[17] C.-Y. Zhou, J. Zhao, Y.-B. Wu, C.-X. Yin, and Y. Pin, “Syn-
thesis, characterization and studies on DNA-binding of a
1
8
new Cu(II) complex with N ,N -bis(l-methyl-4-nitropyrrole-
2
-carbonyl)triethylenetetramine ,” Journal of Inorganic Biochem-
[
5] A. R. Cowley, J. R. Dilworth, P. S. Donnelly, and J. Woollard-
Shore, “Synthesis and characterisation of new homoleptic rhe-
nium thiosemicarbazone complexes ,” Dalton Transactions, no.
istry, vol. 101, no. 1, pp. 10–18, 2007.
[
[
18] ꢀ. ꢀopala, A. Bodoki, L. Oprean, and R. Oprean, “Experimental
techniques employed in the study of metal complexes-DNA-
interactions ,” Farmacia, pp. 1049–1061, 2014.
4
, pp. 748–754, 2003.
[
[
[
6] I. C. Mendes, L. R. ꢀeixeira, R. Lima, H. Beraldo, N. L.
Speziali, and D. X. West, “Structural and spectral studies of
thiosemicarbazones derived from 3- and 4-formylpyridine and
19] P. R. Reddy and A. Shilpa, “Interaction of DNA with small
molecules: role of copper histidyl peptide complexes in DNA
binding and hydrolytic cleavage ,” Indian Journal of Chemistry
3
- and 4-acetylpyridine ,” Journal of Molecular Structure, vol. 559,
no. 1-3, pp. 355–360, 2001.
-
Section A Inorganic, Physical, ꢀeoretical and Analytical
7] S. A. Elsayed, A. M. El-Hendawy, S. I. Mostafa, and I. S.
Butler, “ꢀransition metal complexes of 2-formylpyridinethio-
semicarbazone (HFpyꢀSC) and X-ray crystal structures of
Chemistry, vol. 49, no. 8, pp. 1003–1015, 2010.
[20] S. Chandra, S. Parmar, and Y. Kumar, “Synthesis, spectroscopic,
and antimicrobial studies on bivalent zinc and mercury com-
plexes of 2-formylpyridine thiosemicarbazone ,” Bioinorganic
Chemistry and Applications, vol. 2009, Article ID 851316, 6
pages, 2009.
[
Pd(FpyꢀSC)(PPh )]PF and[Pd(FpyꢀSC)(SCN)] ,” Inorganica
3
6
Chimica Acta, vol. 363, no. 11, pp. 2526–2532, 2010.
8] E. Bermejo, A. Casti n˜ eiras, I. Garc ´ı a, and D. X. West, “Spec-
tral and structural studies of mercury(II) complexes of 2-
pyridineformamide N(4)-dimethylthiosemicarbazone ,” Polyhe-
dron, vol. 22, no. 8, pp. 1147–1154, 2003.
[
21] D. Ashok, E. V. L. Madhuri, M. Sarasija et al., “Synthesis, biologi-
cal evaluation and molecular docking of spirofurochromanone
derivatives as anti-inꢁammatory and antioxidant agents ,” RSC
Advances, vol. 7, no. 41, pp. 25710–25724, 2017.
[
9] P. F. Rapheal, E. Manoj, and M. R. Prathapachandra Kurup,
“
Copper(II) complexes of N(4)-substituted thiosemicarbazones